Canada markets close in 2 hours 52 minutes

Ayala Pharmaceuticals, Inc. (ADXS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.66500.0000 (0.00%)
As of 01:35PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
13
13
692
3,506
3,708
Cost of Revenue
13
13
602
3,506
3,708
Gross Profit
0
0
90
0
0
Operating Expenses
Research Development
24,081
24,081
27,851
29,941
22,406
Selling General and Administrative
12,185
12,185
9,742
9,277
7,371
Total Operating Expenses
36,266
36,266
37,593
39,218
29,777
Operating Income or Loss
-36,266
-36,266
-37,503
-39,218
-29,777
Interest Expense
15,746
15,746
0
260
-
Income Before Tax
-51,984
-51,984
-37,429
-39,478
-29,721
Income Tax Expense
-3,912
-3,912
584
776
425
Income from Continuing Operations
-48,072
-48,072
-38,013
-40,254
-30,146
Net Income
-48,072
-48,072
-38,013
-40,254
-30,146
Net Income available to common shareholders
-48,072
-48,072
-38,013
-40,254
-30,146
Basic EPS
-2.51
-7.99
-13.13
-2.80
-3.06
Diluted EPS
-2.51
-7.99
-13.13
-2.80
-3.06
Basic Average Shares
15,325
6,019
2,895
14,399
9,861
Diluted Average Shares
15,325
6,019
2,895
14,399
9,861